Clinical manifestations in patients with musculoskeletal pain post-chikungunya

Abstract

BACKGROUND AND OBJECTIVES: Chronic clinical manifestations of the chikungunya virus infection are associated with high rates of disability and worsening of quality of life, representing one of the major challenges for global public health. The objective of this study was to investigate the clinical-psycho-functional presentation of the chikungunya virus-infected individuals with complaints of chronic musculoskeletal pain. METHODS: Twenty-two individuals with a diagnosis of chikungunya virus infection and a complaint of persistent musculoskeletal pain (≥3 months) participated in the study. The clinical-psycho-functional evaluation was performed through the intensity and affective-emotional aspect of pain, quality of life, kinesophobia, global perception of post-infection pain recovery and emotional functionality. In the end, the pressure pain threshold and the conditioned pain modulation were evaluated. RESULTS: The clinical presentation of pain revealed long persistence 17.5±7.4 months; predominant in the lower limbs (45.5%); mean intensity (5.5±2.1); mild to moderate affective-emotional changes; moderate kinesophobia (46±6.5) and low overall perception of improvement (1.5±2.5). The Beck Depression Inventory and the visual analog scale for anxiety showed little change. Quality of life presented mild to moderate impairment, and pain modulation showed a slight increase in the pressure pain threshold (6.3%). Clinical manifestations in patients with musculoskeletal pain post-chikungunya Manifestações clínicas em pacientes com dores musculoesqueléticas pós-chikungunya

Sequelas crônicas da chikungunya no contexto endêmico local: relato de experiência em estratégia de saúde da família seguindo o Arco de Maguerez

“…Evidenciou-se que a infecção pelo CHIKV leva a dores persistentes, com características temporais de cronicidade e magnitudes de média e elevada intensidade. Além disso, observou-se que o fator tempo de infecção tem relação direta com o aumento de sintomas de dor e perda da capacidade funcional (ARAUJO et al, 2019).…”

Prevalence, affected joints and intensity of the arthralgias in individuals in the chronic phase of Chikungunya fever

“…The time for full recovery is also unknown, and some patients may remain symptomatic for six to eight years after the infection. In addition to arthralgias, the chronic phase has been associated with physical disabilities and worsening of quality of life in individuals after CF 13,14 , making the clinical and functional evaluation of these patients essential for planning prevention and treatment strategies 15 . There are few studies on the prevalence of arthralgia and which joints are more affected, and these data are important to guide public health measures and the clinical management of individuals affected by CF.…”

Chikungunya: doença emergente no Brasil.

“…A chikungunya apresenta fase crônica, caracterizada por dor moderada persistente, tanto em nível afetivo quanto sensorial, moderada cinesiofobia e piora na qualidade de vida, com a diminuição da ativação inibitória descendente da dor e percepção de pouca melhora após a recuperação da infecção (DE-ARAÚJO et al, 2019).…”

“…Outros sintomas são menos frequentemente relatados na fase tardia como febre, fadiga, cefaleia, síndromes de dor neuropática, doenças cerebrais, deficiência neurossensorial, disestesia e/ou parestesia do carpo, tarso, ou síndromes do túnel cubital, distúrbios digestivos, erupção cutânea, alopécia, prurido, fenômeno de Raynaud, rigidez articular, bursite, tenossinovite e sinovite com ou sem derrame (DE-ARAÚJO et al, 2019).…”